NCT02978222 2022-12-15
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
Marker Therapeutics, Inc.
Phase 2 Terminated
Marker Therapeutics, Inc.
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa